Mirum Pharmaceuticals (MIRM) Treasury Shares (2018 - 2026)
Mirum Pharmaceuticals (MIRM) recorded quarterly Treasury Shares of $487498.0 in Q1 2026, up 37.81% quarter-over-quarter from $353743.0 in Q4 2025, and up 37.81% on a YoY basis from $353743.0 in Q1 2025.
Mirum Pharmaceuticals (MIRM) Treasury Shares (2018 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Treasury Shares history runs 9 years deep, the most recent figure standing at $487498.0 for Q1 2026.
- In Q1 2026, Treasury Shares rose 37.81% year-over-year to $487498.0; the TTM figure through Mar 2026 stood at $487498.0 (up 37.81% YoY), while the FY2025 annual figure was $353743.0, up 24.14% from the prior year.
- Treasury Shares was $487498.0 for Q1 2026 at Mirum Pharmaceuticals, up from $353743.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $487498.0 in Q1 2026 to a low of $22270.0 in Q3 2022.
- Historically, Treasury Shares has averaged $251279.2 across 5 years, with a median of $289862.5 in 2024.
- The sharpest annual moves came in 2022 and 2024: Treasury Shares plunged 85.71% in 2022, then soared 120.92% in 2024.
- A 5-year view of Treasury Shares shows it stood at $22270.0 in 2022, then soared by 563.83% to $147835.0 in 2023, then surged by 92.75% to $284955.0 in 2024, then grew by 24.14% to $353743.0 in 2025, then soared by 37.81% to $487498.0 in 2026.
- The last three Treasury Shares figures came in at $487498.0 (Q1 2026), $353743.0 (Q4 2025), and $353743.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mirum Pharmaceuticals | 6.29 Bn | 5.90 Bn | 131.08 Mn | 487,498.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 487,498.00 |
| Mar 31, 2026 | 487,498.00 |
| Dec 31, 2025 | 353,743.00 |
| Dec 31, 2025 | 353,743.00 |
| Sep 30, 2025 | 353,743.00 |
| Sep 30, 2025 | 353,743.00 |
| Jun 30, 2025 | 353,743.00 |
| Jun 30, 2025 | 353,743.00 |
| Mar 31, 2025 | 353,743.00 |
| Mar 31, 2025 | 353,743.00 |
| Dec 31, 2024 | 284,955.00 |
| Dec 31, 2024 | 284,955.00 |
| Sep 30, 2024 | 284,955.00 |
| Sep 30, 2024 | 284,955.00 |
| Jun 30, 2024 | 294,770.00 |
| Jun 30, 2024 | 294,770.00 |
| Mar 31, 2024 | 300,085.00 |
| Mar 31, 2024 | 300,085.00 |
| Dec 31, 2023 | 147,835.00 |
| Dec 31, 2023 | 147,835.00 |